Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis-Reference-Cited by-同舟云学术

Biapenem, a Carbapenem Antibiotic, Elicits Mycobacteria Specific Immune Responses and Reduces the Recurrence of Tuberculosis

Published:2023-08-17 Issue:4 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Pahuja Isha¹²,Verma Akanksha¹,Ghoshal Antara¹,Mukhopadhyay Suparba¹,Kumari Anjna¹,Shaji Aishwarya¹,Chaturvedi Shivam¹,Dwivedi Ved Prakash¹^ORCID,Bhaskar Ashima¹^ORCID

Affiliation:

1. Immunobiology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India

2. Department of Molecular Medicine, Jamia Hamdard University, New Delhi, India

Abstract

Tuberculosis (TB) caused by Mycobacterium tuberculosis ( M.tb ) tops the list of infectious killers around the globe. The emergence of drug-resistant variants of M.tb has been a major hindrance toward realizing the “END TB” goal.

Funder

Department of Biotechnology, Ministry of Science and Technology, India

Department of Science and Technology, Ministry of Science and Technology, India

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.00858-23

Reference52 articles.

1. Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study

2. Impact of the COVID-19 Pandemic on Tuberculosis Control: An Overview

3. WHO. 2021. Global tuberculosis report 2021. https://www.who.int/publications-detail-redirect/9789240037021. Accessed 2 June 2022.

4. WHO. 1999. What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. https://apps.who.int/iris/bitstream/handle/10665/65979/WHO_CDS_CPC_T?sequence=1. Accessed 30 August 2022.

5. Challenges Associated with Current and Future TB Treatment

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence;Microbiology Spectrum;2024-07-02

2. Bergenin potentiates BCG efficacy by enriching mycobacteria-specific adaptive memory responses via the Akt-Foxo-Stat4 axis;Tuberculosis;2024-07

3. Natural products in anti-tuberculosis host-directed therapy;Biomedicine & Pharmacotherapy;2024-02